- Who can participate: Individuals aged 18 to 65 who experience frequent migraines and are otherwise healthy may be eligible to participate. Key eligibility factors include a history of migraines for at least one year and the occurrence of four or more migraine days per month.
- Study details: Participants will be required to attend regular clinic visits and maintain a diary to track migraine occurrences and any side effects. The investigational treatment will be compared to a placebo, which is an inactive substance designed to resemble the treatment.